HNF4A and lung carcinoma: Our investigation revealed that Apatinib reduces the expressions of TCF, GBP, and LRP6 in the Wnt signaling pathway significantly to inhibit the pathway, thus suppressing tumor and inhibiting the progression of lung cancer.